Advances in the transepithelial transport of nanoparticles

Drug Discovery Today

Volumn 21, Issue 7, 2016, Pages 1155-1161

  Yu, Miaorong ^a,b   Yang, Yiwei ^a,b   Zhu, Chunliu ^a   Guo, Shiyan ^a   Gan, Yong ^a,b  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE;

DRUG DELIVERY SYSTEM; HUMAN; INTESTINAL AVAILABILITY; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE EPITHELIUM CELL; M CELL MEDIATED PATHWAY; MOLECULAR INTERACTION; NONHUMAN; PARACELLULAR PATHWAY; REVIEW; TRANSCYTOSIS; TRANSENTEROCYTIC PATHWAY; TRANSEPITHELIAL TRANSPORT; TRANSPORT AT THE CELLULAR LEVEL; ANIMAL; EPITHELIUM CELL; METABOLISM; TISSUE DISTRIBUTION;

ANIMALS; BIOLOGICAL TRANSPORT; EPITHELIAL CELLS; HUMANS; INTESTINAL ABSORPTION; NANOPARTICLES; TISSUE DISTRIBUTION;

EID: 84971631198     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2016.05.007     Document Type: Review

References (59)

1. M. Alonso-Sande, and et al. Development of PLGA-mannosamine nanoparticles as oral protein carriers Biomacromolecules 14 2013 4046 4052
2. P. Calleja, and et al. Controlled release, intestinal transport, and oral bioavailablity of paclitaxel can be considerably increased using suitably tailored pegylated poly(anhydride) nanoparticles J. Pharm. Sci. 104 2015 2877 2886
3. J. Guo, and et al. Amphiphilic polyallylamine based polymeric micelles for siRNA delivery to the gastrointestinal tract: in vitro investigations Int. J. Pharm. 447 2013 150 157
4. E. Roger, and et al. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery Nanomedicine 5 2010 287 306
5. I. Pereira de Sousa, and et al. Insulin loaded mucus permeating nanoparticles: addressing the surface characteristics as feature to improve mucus permeation Int. J. Pharm. 500 2016 236 244
6. H. Harde, and et al. Development of stabilized glucomannosylated chitosan nanoparticles using tandem crosslinking method for oral vaccine delivery Nanomedicine 9 2014 2511 2529
7. X. Hu, and et al. Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery Nanoscale 8 2016 7024 7035
8. G. Di Pasquale, and et al. BAAV transcytosis requires an interaction with beta-1-4 linked-glucosamine and gp96 PLoS One 5 2010 e9336
9. J.A. Cuthbert Hepatitis A: old and new Clin. Microbiol. Rev. 14 2001 38 58
10. Y. Yin, and et al. CpG DNA assists the whole inactivated H9N2 influenza virus in crossing the intestinal epithelial barriers via transepithelial uptake of dendritic cell dendrites Mucosal Immunol. 8 2015 799 814
11. S.K. Lai, and et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus Proc. Natl. Acad. Sci. U. S. A. 104 2007 1482 1487
12. E. Acosta Bioavailability of nanoparticles in nutrient and nutraceutical delivery Curr. Opin. Colloid Interface Sci. 14 2009 3 15
13. M.C. Chen, and et al. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules Adv. Drug Deliv. Rev. 65 2013 865 879
14. A. Alfsen, and et al. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1 J. Immunol. 166 2001 6257 6265
15. J.M. Kyd, and A.W. Cripps Functional differences between M cells and enterocytes in sampling luminal antigens Vaccine 26 2008 6221 6224
16. V. Chamcha, and et al. Oral immunization with a recombinant Lactococcus lactis-expressing HIV-1 antigen on group A Streptococcus pilus induces strong mucosal immunity in the gut J. Immunol. 195 2015 5025 5034
17. M.B. Gonzalez-Hernandez, and et al. Efficient norovirus and reovirus replication in the mouse intestine requires microfold (M) cells J. Virol. 88 2014 6934 6943
18. B. Singh, and et al. Combinatorial approach of antigen delivery using M cell-homing peptide and mucoadhesive vehicle to enhance the efficacy of oral vaccine Mol. Pharm. 12 2015 3816 3828
19. G. Sahay, and et al. Endocytosis of nanomedicines J. Control. Release 145 2010 182 195
20. S. Mazzaferro, and et al. Oral delivery of anticancer drugs III: formulation using drug delivery systems Drug Discov. Today 18 2013 99 104
21. J. Wang, and et al. Improved oral absorption of doxorubicin by amphiphilic copolymer of lysine-linked ditocopherol polyethylene glycol 2000 succinate: in vitro characterization and in vivo evaluation Mol. Pharm. 12 2015 463 473
22. M.J. O'Neill, and et al. Mechanistic studies on the uptake and intracellular trafficking of novel cyclodextrin transfection complexes by intestinal epithelial cells Int. J. Pharm. 413 2011 174 183
23. J. Zhang, and et al. Mechanism of enhanced oral absorption of morin by phospholipid complex based self-nanoemulsifying drug delivery system Mol. Pharm. 12 2015 504 513
24. M. El-Sayed, and et al. Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers Int. J. Pharm. 265 2003 151 157
25. D. Hubbard, and et al. Transepithelial transport of PAMAM dendrimers across isolated rat jejunal mucosae in ussing chambers Biomacromolecules 15 2014 2889 2895
26. D. Hubbard, and et al. Transepithelial transport of PAMAM dendrimers across isolated human intestinal tissue Mol. Pharm. 12 2015 4099 4107
27. G. Thiagarajan, and et al. Evidence of oral translocation of anionic G6.5 dendrimers in mice Mol. Pharm. 10 2013 988 998
28. B. He, and et al. The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells Biomaterials 34 2013 6082 6098
29. M.P. Desai, and et al. Gastrointestinal uptake of biodegradable microparticles: effect of particle size Pharm. Res. 13 1996 1838 1845
30. X. Zhu, and et al. Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery Mol. Pharm. 11 2014 317 328
31. J. Jinno, and et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs J. Control. Release 111 2006 56 64
32. D. Xia, and et al. Enhanced transport of nanocage stabilized pure nanodrug across intestinal epithelial barrier mimicking Listeria monocytogenes Biomaterials 37 2015 320 332
33. R.R. Sawant, and et al. The architecture of ligand attachment to nanocarriers controls their specific interaction with target cells J. Drug Target. 16 2008 596 600
34. A.M. Bannunah, and et al. Mechanisms of nanoparticle internalization and transport across an intestinal epithelial cell model: effect of size and surface charge Mol. Pharm. 11 2014 4363 4373
35. N.J. Omid, and et al. Preparation and characterization of novel derivatives of chitosan and trimethyl chitosan conjugated with dipeptides and vitamin B12 as candidates for oral delivery of insulin J. Polymer Res. 21 2014 510
36. J. Zhang, and et al. Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages Biomaterials 34 2013 3667 3677
37. E.F. Craparo, and et al. Galactosylated polymeric carriers for liver targeting of sorafenib Int. J. Pharm. 466 2014 172 180
38. E. Roger, and et al. Folic acid functionalized nanoparticles for enhanced oral drug delivery Mol. Pharm. 9 2012 2103 2110
39. N. Zhang, and et al. Transport characteristics of wheat germ agglutinin-modified insulin-liposomes and solid lipid nanoparticles in a perfused rat intestinal model J. Nanosci. Nanotechnol. 6 2006 2959 2966
40. W. He, and et al. FcRn-mediated antibody transport across epithelial cells revealed by electron tomography Nature 455 2008 542 546
41. E.M. Pridgen, and et al. Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery Sci. Transl. Med. 5 2013 213ra167
42. W. Du, and et al. Transferrin receptor specific nanocarriers conjugated with functional 7peptide for oral drug delivery Biomaterials 34 2013 794 806
43. T.A. Al-Hilal, and et al. Functional transformations of bile acid transporters induced by high-affinity macromolecules Scientific Reports 4 2014 4163
44. A. Ziegler Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans Adv. Drug Deliv. Rev. 60 2008 580 597
45. L.N. Patel, and et al. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives Pharm. Res. 24 2007 1977 1992
46. C.H. Wu, and et al. Enhanced non-endocytotic uptake of mesoporous silica nanoparticles by shortening the peptide transporter arginine side chain ACS Appl. Mater. Interfaces 5 2013 12244 12248
47. J.H. Eldridge, and et al. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches J. Control. Release 11 1990 205 214
48. T. Ma, and et al. PLGA-lipid liposphere as a promising platform for oral delivery of proteins Colloids Surf. B Biointerfaces 117 2014 512 519
49. H. Yuan, and et al. Studies on oral absorption of stearic acid SLN by a novel fluorometric method Colloids Surf. B Biointerfaces 58 2007 157 164
50. T. Wang, and et al. Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties Int. J. Pharm. 436 2012 351 358
51. H.H. Salman, and et al. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles Vaccine 25 2007 8123 8132
52. V. Fievez, and et al. Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination Eur. J. Pharm. Biopharm. 73 2009 16 24
53. N. Mishra, and et al. Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B J. Drug Target. 19 2011 67 78
54. M.K. Yoo, and et al. Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique Biomaterials 31 2010 7738 7747
55. T. Jiang, and et al. Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan Biomaterials 35 2014 2365 2373
56. P. Jani, and et al. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency J. Pharm. Pharmacol. 42 1990 821 826
57. P.G. Jenkins, and et al. Microparticulate absorption from the rat intestine J. Control. Release 29 1994 339 350
58. S. Attili-Qadri, and et al. Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption Proc. Natl. Acad. Sci. U. S. A. 110 2013 17498 17503
59. M. Niu, and et al. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose Eur. J. Pharm. Biopharm. 81 2012 265 272